ROHTO PHARMACEUTICAL CO.,LTD. Logo

ROHTO PHARMACEUTICAL CO.,LTD.

Manufactures OTC drugs, skincare, and cosmetics with a focus on eye and dermatological health.

4527 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
大阪市生野区巽西1丁目8番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Rohto Pharmaceutical Co., Ltd. is a multinational company that manufactures and markets pharmaceutical products, cosmetics, and functional foods. Its core business centers on over-the-counter (OTC) drugs and skincare, with a significant focus on eye care and dermatological products. The company's portfolio includes a wide range of health and beauty care items. Committed to innovation, Rohto actively engages in research and development, conducting clinical trials for new therapeutic agents and leveraging advanced technologies to develop novel health solutions. The company's mission is to support the physical and mental health of people worldwide, contributing to the overall well-being of individuals and society.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-11 04:04
Registration Form
訂正確認書
Japanese 9.3 KB
2025-07-11 04:03
Annual Report
訂正有価証券報告書-第89期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-07-01 02:29
Regulatory News Service
臨時報告書
Japanese 30.2 KB
2025-06-25 02:08
Governance Information
内部統制報告書-第89期(2024/04/01-2025/03/31)
Japanese 26.7 KB
2025-06-25 02:07
Registration Form
有価証券報告書-第89期(2024/04/01-2025/03/31)
Japanese 1.9 MB
2025-06-25 02:07
Registration Form
確認書
Japanese 9.4 KB
2025-05-12 03:40
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.0 KB
2025-04-14 02:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.0 KB
2025-03-14 01:44
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.1 KB
2025-02-27 03:52
Share Issue/Capital Change
訂正臨時報告書
Japanese 37.8 KB
2025-02-26 08:00
Share Issue/Capital Change
臨時報告書
Japanese 44.8 KB
2025-02-13 02:46
Major Shareholding Notification
大量保有報告書
Japanese 38.2 KB
2024-11-14 02:17
Interim Report
確認書
Japanese 9.5 KB
2024-11-14 02:16
Interim Report
半期報告書-第89期(2024/04/01-2025/03/31)
Japanese 290.6 KB
2024-07-01 08:37
Regulatory News Service
臨時報告書
Japanese 28.7 KB

Automate Your Workflow. Get a real-time feed of all ROHTO PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ROHTO PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.